16 May, EOD - Indian

SENSEX 82330.59 (-0.24)

Nifty 50 25019.8 (-0.17)

Nifty Bank 55354.9 (0.00)

Nifty IT 37972.35 (-0.84)

Nifty Midcap 100 57060.5 (0.94)

Nifty Next 50 67078.95 (1.29)

Nifty Pharma 21633.2 (-0.08)

Nifty Smallcap 100 17560.4 (1.86)

16 May, EOD - Global

NIKKEI 225 37753.72 (0.00)

HANG SENG 23345.05 (-0.46)

S&P 5960.5 (0.26)

Login/Signup
Careers
LOGIN HERE
Cancel

companylogoCiturgia Biochemicals Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 506373 | NSE Symbol : CITURGIBIO | ISIN : INE795B01031 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
28-Apr-2025 28-Apr-2025 Others Outcome of Board meeting dated 28th April, 2025 related to Reclassification of Promoter/Promoter Group category to Public Category shareholders Minutes of Board Meeting dated 28.04.2025 regarding reclassification of Promoter/Promoter Group to Public Category (As Per BSE Announcement Dated on 29.04.2025) SUBMISSION OF APPLICATION FOR RECLASSIFICATION OF STATUS OF PROMOTER TO PUBLIC (As Per BSE Announcement dated on 15.05.2025)
10-Feb-2025 14-Feb-2025 Quarterly Results CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve UNAUDITED FINANCIAL RESULT FOR THE QUARTER ENDED ON 31.12.2024 Unaudited Financial Result for the quarter ended on 31.12.2024 (As Per BSE Announcement Dated on: 27/02/2025)
05-Nov-2024 14-Nov-2024 Quarterly Results CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Unaudited Financial Results of the Company for the Quarter end half year ended on 30th September 2024. UNAUDITED FINANCIAL RESULT FOR QUARTER AND HALF YEAR ENDED ON 30.09.2024 (As Per BSE Announcement dated on 19.11.2024)
28-Aug-2024 31-Aug-2024 AGM CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2024 inter alia to consider and approve Intimation of Annual General Meeting Outcome of Board Meeting dated 31.08.2024 (As per BSE Announcement Dated on 31/08/2024)
07-Aug-2024 14-Aug-2024 Quarterly Results CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited Financial Results for the quarter ended on 30th June 2024.
22-May-2024 22-May-2024 Accounts Audited Financial Result For the quarter and year ended on 31st March, 2024 Revised Audited Financial Result for the quarter and year ended on 31st March, 2024 (As Per BSE Announcement Dated on 27.05.2024)
16-May-2024 16-May-2024 Quarterly Results CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 inter alia to consider and approve AUDITED FINANCIAL RESULT FOR THE QUARTER AND YEAR ENDED ON 31ST MARCH 2024.
31-Jan-2024 14-Feb-2024 Quarterly Results CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve unaudited Financial Results for the Quarter ended on 31st December 2023. Unaudited Financial Result For the Quarter ended on 31st December, 2023 (As per BSE Announcement Dated on 14/02/2024)
06-Dec-2023 14-Nov-2023 Quarterly Results CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve INTIMATION OF BOARD MEETING 30.09.2023 UNAUDITED FINANCIAL RESULT FOR THE QUARTER ENDED ON 30.09.2023 (As Per BSE Announcement dated on 03.01.2024)
29-Aug-2023 01-Sep-2023 AGM INTIMATION OF BOARD MEETING AGM OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on 01/09/2023)
04-Aug-2023 14-Aug-2023 Quarterly Results CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve unaudited Financial Results for the quarter ended on 30th June 2023 Unaudited Financial Result For The Quarter Ended 30th June, 2023 (As Per BSE Announcement dated on 21.10.2023)
22-May-2023 30-May-2023 Quarterly Results CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve audited Financial Results for the quarter and year ended on 31st March 2023. AUDITED FINANCIAL; RESULT FOR THE QUARTER AND YEAR ENDED ON 31.03.2023 (As Per BSE Announcement Dated on 27.07.2023) REVISED AUDITED FINANCIAL RESULT FOR THE QUARTER AND YEAR ENDED ON 31.03.2023 (As Per BSE Announcement Dated on 20/10/2023) AUDITED FINANCIAL RESULT FOR THE HALF YEAR AND YEAR ENDED 31.03.2023 (As Per BSE Announcement dated on 29.12.2023)
08-Feb-2023 14-Feb-2023 Quarterly Results CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve unaudited Financial Results of the Company for the Quarter ended on 31st December 2022. Unaudited Financial Results for Quarter ended on 31st December, 2022. (As Per BSE Announcement dated on 15.02.2023) Revised Unaudited Financial Results for Quarter ended on 31st December, 2022 along with Limited review report (As per BSE Announcement Dated on 28/02/2023)
25-Nov-2022 28-Nov-2022 Others CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/11/2022 inter alia to consider and approve the proposal of withdrawal of application made for reclassification from Promoter Group category to Public category shareholders in accordance with Regulations 30 and 31A SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended. withdrawal of application made for reclassification from 'Promoter/Promoter Group' category to 'Public' category shareholders, pursuant to Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('LODR Regulations') Revised Outcome of Meeting of Board of Directors held on November 28, 2022 (As per BSE Announcement Dated on 28/11/2022)
07-Nov-2022 14-Nov-2022 Quarterly Results CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve unaudited Financial Results for the half year ended on 30th September 2022 UNAUDITED FINANCIAL RESULT FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2022 (As per BSE Announcement Dated on 23/01/2023) Revised Unaudited Financial Results for Quarter and half year ended 30th September, 2022 (As per BSE Announcement Dated on 28/02/2023)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-9769005430
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
+91-8657545825  

subscription@capitalmarket.com

For Capital Market Online Product related queries :
+91-8657545825  

financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +